Effect of Tobacco Advocacy at the State Level

州一级烟草宣传的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): Tobacco use is responsible for 35 percent of cancer deaths, including cancers of the lung, oral cavity, larynx, esophagus, bladder, stomach, pancreas, kidney, uterus, cervix, and liver, as well as heart and other diseases. The tobacco industry develops and implements specific strategies to promote adoption, continuation, and public tolerance of smoking and to counter efforts by public health professionals to reduce tobacco use. In this way, it serves as a "vector" for the spread of tobacco-induced disease. As with any disease, it is important to understand the vector to develop and implement effective prevention and control strategies. Understanding the tobacco industry's strategies and tactics will increase the likelihood of successful development and implementation of effective tobacco use prevention and control policies and, hence, reduce tobacco-induced disease and death. Public policies, including smoke free environments, aggressive media campaigns, and tax increases, are cost-effective interventions to prevent and reduce tobacco use. There have been major changes in the environment for tobacco control policy making and program implementation in recent years: during the 1990s, state initiatives and settlements of major litigation against the tobacco industry yielded substantial resources for tobacco control programs, which was associated with significant drops in smoking and smoking-induced disease. Despite these successes, during the past few years there has been a reduction in public attention and funding for tobacco control. This project seeks to continue our research strategy of combining case studies and quantitative methods to address four specific aims in this rapidly changing environment: (1) Document and analyze variations in tobacco control policy making and program implementation across a variety of states with varying levels of success at developing and implementing tobacco control programs, to serve as the basis for recommendations to create the most effective and efficient tobacco control strategies and policies; (2) Identify and describe new and evolving tobacco industry strategies for using third party allies to oppose or weaken tobacco control policies; (3) Continue our comparative analysis of the effectiveness of tobacco control strategies in different legal and financial contexts, to identify the most cost-effective strategies; and (4) Investigate the effects of smoke free policies on bar and casino businesses.
描述(由申请人提供):烟草使用导致35%的癌症死亡,包括肺癌、口腔癌、喉癌、食道癌、膀胱癌、胃癌、胰腺癌、肾癌、子宫癌、宫颈癌和肝癌,以及心脏病和其他疾病。烟草业制定和实施具体战略,以促进吸烟的采用、持续和公众容忍,并反击公共卫生专业人员减少烟草使用的努力。这样,它就成了烟草引起的疾病传播的“媒介”。与任何疾病一样,重要的是要了解病媒,以制定和实施有效的预防和控制战略。了解烟草业的战略和战术将增加成功制定和实施有效的烟草使用预防和控制政策的可能性,从而减少烟草引起的疾病和死亡。公共政策,包括无烟环境、积极的媒体宣传和增税,是预防和减少烟草使用的具有成本效益的干预措施。近年来,烟草控制政策制定和计划实施的环境发生了重大变化:在20世纪90年代,针对烟草业的重大诉讼的州倡议和和解为烟草控制计划提供了大量资源,这与吸烟和吸烟引起的疾病的显着下降有关。尽管取得了这些成就,但在过去几年中,公众对烟草控制的关注和资助有所减少。该项目旨在继续我们的研究策略,结合案例研究和定量方法,以解决四个具体目标在这个快速变化的环境:(1)记录和分析不同州在制定和实施烟草控制规划方面的成功程度不同的烟草控制政策制定和规划实施的差异,作为制定最有效和最高效的烟草控制战略和政策的建议基础;(2)确定和描述烟草业利用第三方盟友反对或削弱烟草控制政策的新的和不断发展的战略;(3)继续对不同法律和财政环境下烟草控制战略的有效性进行比较分析,以确定最具成本效益的战略;(4)调查禁烟政策对酒吧和赌场业务的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STANTON ARNOLD GLANTZ其他文献

STANTON ARNOLD GLANTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STANTON ARNOLD GLANTZ', 18)}}的其他基金

Training and Education
培训和教育
  • 批准号:
    9340092
  • 财政年份:
    2017
  • 资助金额:
    $ 60.12万
  • 项目类别:
Improved Models to Inform Tobacco Product Regulation
改进模型以告知烟草产品监管
  • 批准号:
    8737818
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
CORE A: ADMINISTRATION
核心 A:管理
  • 批准号:
    10259835
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
CORE A: ADMINISTRATION
核心 A:管理
  • 批准号:
    10468881
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
Improved Models to Inform Tobacco Product Regulation
改进模型以告知烟草产品监管
  • 批准号:
    8581845
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
Improved Models to Inform Tobacco Product Regulation
改进模型以告知烟草产品监管
  • 批准号:
    9379072
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
Improved Models to Inform Tobacco Product Regulation
改进模型以告知烟草产品监管
  • 批准号:
    9134068
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
Developmental/Pilot Projects p451-488
开发/试点项目 p451-488
  • 批准号:
    8592360
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
Core A: Administrative p386-402
核心 A:行政 p386-402
  • 批准号:
    8592294
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:
Improved Models to Inform Tobacco Product Regulation
改进模型以告知烟草产品监管
  • 批准号:
    9340081
  • 财政年份:
    2013
  • 资助金额:
    $ 60.12万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.12万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了